Publication

Core protocol for ECDC studies of COVID19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2, version 1.0. Stockholm: ECDC; 2021 Oct, 8.
Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID-19 pandemic. Influenza Other Respir Viruses. 2022

Bergeri I, Lewis HC, Subissi L, Nardone A, Valenciano M, Cheng B, Glonti K, Williams B, Abejirinde IO, Simniceanu A, Cassini A, Grant R, Rodriguez A, Vicari A, Al Ariqi L, Azim T, Wijesinghe PR, Rajatonirina SC, Okeibunor JC, Le LV, Katz M, Vaughan A, Jorgensen P, Freidl G, Pebody R, Van Kerkhove MD

Jan;16(1):7-13. doi: 10.1111/irv.12915. Epub 2021 Oct 5. PMID: 34611986; PMCID: PMC8652791

Available here

Cohort study to measure COVID-19 vaccine effectiveness among health workers in the WHO European Region: guidance document

World Health Organization. Regional Office for Europe. 2021

Available here

Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (‎SARI)‎ hospitalisations associated with laboratory-confirmed SARS-CoV-2: an evaluation using the test-negative design: guidance document

World Health Organization. Regional Office for Europe. 2021

Available here

Household transmission of SARS-CoV-2: a prospective observational study in Bosnia and Herzegovina, August–December 2020

Musa S, Kissling E,Valenciano M,Dizdar F, Blažević M,Jogunčić A, Palo M,Merdrignac L, Pebody R, Jorgense P.

International Journal of Infectious Diseases. 2021 September, 28 DOI

Available here

Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018

Merdrignac L, Aït El Belghiti F, Pandolfi E, Jané M, Murphy J, Fabiánová K, García Cenoz M, Flem E, Guillot S, Tozzi AE, Carmona G, Habington A, Zavadilová J, Navasués A, Bøås H, Lévy-Brühl D, Ferretti B, Lanaspa M, O’Sullivan N, Křížová P, Fernandino L, Bekkevold T, Hanslik T, Muñoz-Almagro C, Bacci S, Spiteri G, Valenciano M, Moren A, PERTINENT Group.

Euro Surveill. 2021;26(4):pii=1900762

Available here

Decline of tuberculosis notification rate in different populations and regions in Portugal, 2010-2017.

Sentís A, Prats-Uribe A, Peixoto VR, Caylà JA, Gomes MD, Sousa S, Duarte R, Carvalho I, Carvalho C.

Pulmonology. 2021 Sep 17:S2531-0437(21)00158-6. doi: 10.1016/j.pulmoe.2021.08.002. Epub ahead of print. PMID: 34544672.

Available here

Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization, Vaccine, 2021 July, 5.

Minal K. Patel, Isabel Bergeri, Joseph S. Bresee, Benjamin J. Cowling, Natasha S. Crowcroft, Kamal Fahmy, Siddhivinayak Hirve, Gagandeep Kang, Mark A. Katz, Claudio F. Lanata, Maïna L’Azou Jackson, Sudhir Joshi, Marc Lipsitch, Jason M. Mwenda, Francisco Nogareda, Walter A. Orenstein, Justin R. Ortiz, Richard Pebody, Stephanie J. Schrag, Peter G. Smith, Padmini Srikantiah, Lorenzo Subissi, Marta Valenciano, David W. Vaughn, Jennifer R. Verani, Annelies Wilder-Smith, Daniel R. Feikin

Available here

ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2

Short Communication. World Health Organization Seroepidemiology Technical Working Group. Influenza Other Respir Viruses.

2021 June, 26

Available here

World Health Organization. (‎2021)‎. Evaluation of COVID-19 vaccine effectiveness: interim guidance, 17 March 2021. World Health Organization

Patel MK, Bergeri I, Bresee JS, Cowling BJ, Crowcroft NS, Fahmy K, Hirve S, Kang G, Katz MA, Lanata CF, L’Azou Jackson M, Joshi S, Lipsitch M, Mwenda JM, Nogareda F, Orenstein WA, Ortiz JR, Pebody R, Schrag SJ, Smith PG, Srikantiah P, Subissi L, Valenciano M, Vaughn DW, Verani JR, Wilder-Smith A, Feikin DR.

Vaccine. 2021 Jul 5;39(30):4013-4024. doi: 10.1016/j.vaccine.2021.05.099. Epub 2021 Jun 1. PMID: 34119350; PMCID: PMC8166525

Available here

Référencement Centrales d'achats

Hébergement de données de santé

Nous sommes Hébergeur de Données de Santé (HDS) à caractère personnel depuis 2012 avec la certification ISO 27001/HDS depuis 2019.

En savoir plus

Engagement et éthique

Découvrez nos engagements et valeurs dans notre charte